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Abstract
Background: Little is known about the health status of prisoners in Switzerland. The aim of this study was to
provide a detailed description of the health problems presented by detainees in Switzerland’s largest remand
prison.
Methods: In this retrospective cross-sectional study we reviewed the health records of all detainees leaving
Switzerland’s largest remand prison in 2007. The health problems were coded using the International Classification
for Primary Care (ICPC-2). Analyses were descriptive, stratified by gender.
Results: A total of 2195 health records were reviewed. Mean age was 29.5 years (SD 9.5); 95% were male; 87.8%
were migrants. Mean length of stay was 80 days (SD 160). Illicit drug use (40.2%) and mental health problems
(32.6%) were frequent, but most of these detainees (57.6%) had more generic primary care problems, such as skin
(27.0%), infectious diseases (23.5%), musculoskeletal (19.2%), injury related (18.3%), digestive (15.0%) or respiratory
problems (14.0%). Furthermore, 7.9% reported exposure to violence during arrest by the police.
Conclusion: Morbidity is high in this young, predominantly male population of detainees, in particular in relation
to substance abuse. Other health problems more commonly seen in general practice are also frequent. These
findings support the further development of coordinated primary care and mental health services within detention
centers.
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Background
Prisoners are an underserved and vulnerable population.
They frequently have had limited previous access to
healthcare due to educational, social and economic dis-
advantage [1,2]. Prison has been identified as a signifi-
cant opportunity to address the health needs of
vulnerable groups. In particular, prison health services
aim to reduce inequalities by providing primary care
services that are similar in range and quality to those
available in the community [3]. Addiction, psychiatric
problems and infectious disease are recognized as
important health problems in prison, their extent varies
widely from one setting to another [1]. Belgian prisoners
have been shown to make substantial use of primary
care services during incarceration [4]. In US jails 36.9%
of inmates in 2002 reported having a current medical
problem but only 42% of them said that they had seen a
health care professional about it. The most frequent
specific health problems were dental problems (25%),
arthritis (13%), followed by hypertension (11%) and
asthma (10%). Furthermore, 13% of inmates reported
being injured since admission [5].
The frequency and range of health problems encoun-
tered in prisons should shape the composition and com-
petence profile of prison health care services. Yet little is
known about the primary care needs of detainees in
most European countries, and no detailed description is
available for Switzerland. The aim of this study was thus
to provide a detailed description of the health problems
of detainees in Switzerland’s largest remand prison.
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Methods
Setting
In 2007, Switzerland had 115 institutions for 5715 pris-
oners of whom 29% were in pre-trial detention. This
country had an average of 76 prisoners per 100’0000 resi-
dents, which is one of the lowest rates in the world [6].
Geneva however topped the national statistics with an
average of 200 inmates per 100,000 residents [7]. The
majority of detainees in Swiss jails were male (93.6%) and
of foreign origin (81.4%) [6]. Furthermore, the canton of
Geneva has the highest proportion of foreigners (38.3%)
among its general resident population [8].
The study took place in Switzerland’s largest remand
prison, situated in Geneva and built in 1977. Initially
conceived to receive 270 prisoners, this prison is over-
crowded with a mean occupation rate of 169% in 2007.
At the time the study took place, 10 to 20% of detainees
were sentenced prisoners waiting to be transferred to
another institution. The medical unit attached to Gen-
eva University Hospitals is completely independent of
the prison administration. It offers a low-threshold pri-
mary care approach to health care and employs 37
health professionals, including general practitioners,
nurses, psychiatrists, psychologists and dentists. The
facility operates 24 h/day with a nurse present at all
times. All detainees admitted to the facility are sub-
mitted to a health assessment by primary health care
nurses within the first 8 hours of their admission. This
evaluation acts as triage to identify any health problems
requiring medical attention, such as allergies, injuries,
breathing problems, mental health problems including
suicidal ideas, addiction, regular medical treatment, sus-
picion of tuberculosis or allegations of violence during
arrest. The nurse evaluation is also an introduction to
the facility’s health service. When necessary, nurses refer
detainees immediately to a primary care physician. At
any time, inmates can ask for a medical consultation
and are then addressed to a primary care physician.
Referrals to the psychiatric team occur via the primary
care physician.
Instrument and design
This retrospective, cross-sectional study assessed the
health problems of all detainees leaving the facility
between January 1st and December 31st in 2007. All
health records (nurse evaluation forms and medical
files) were reviewed and coded using the French version
of the international classification of primary care, second
edition (ICPC-2) [9,10]. This coding is particularly
adapted to primary care where complaints do not always
lead to a specific diagnosis. The questionnaire (addi-
tional file 1) grouped ICPC-2 diagnoses within six cate-
gories created to reflect the clinical reality of prison
medicine: 1. symptoms without precise diagnosis, 2. sub-
stance abuse or self-harm, 3. infections, 4. general inter-
nal medicine, 5. psychiatry and 6. injuries.
Daily use of at least one cigarette defined tobacco use.
The first three questions of the Alcohol Use Disorders
Identification Test (AUDIT) were used to assess alcohol
misuse defined as excessive drinking including heavy
drinking, binge drinking or both, or alcohol abuse or
dependence. The standard 10-item AUDIT [11] has
been tested and validated in primary care, but its length
precludes its use in jail settings. The derived three-item
AUDIT-C has shown good screening performance for
alcohol use disorders and risky drinking, and is now
considered a reliable alternative to the standard AUDIT
score [12,13]. All detainees were asked about illicit sub-
stance use during the initial nurse evaluation. Prisoners
referred to the primary care physician were systemati-
cally screened again for substance use during the first
consultation. Active cocaine, respectively heroin use was
classified as positive if used during the last 30 days
before entering the prison. Previous cocaine, respectively
heroin use was recorded if prisoners reported lifetime
but no active use. Regular use of cannabis or benzodia-
zepine (more than once a week, without medical pre-
scription) was recorded if the prisoner reported use
during the last 30 days before admission to the prison.
Cocaine, heroin and cannabis use were grouped as “illi-
cit drug use”. All detainees were asked about exposure
to violence during arrest in the initial nurse evaluation
and referred to the primary care physician if such expo-
sure was reported. Socio-demographic data were age,
gender, nationality (as a proxy for origin). Length of stay
was recorded as it could be correlated with morbidity.
Detainees who stay longer in prison have a higher prob-
ability of developing health problems and being in con-
tact with health services.
The methodology and the coding instrument were
pre-tested over a three-month period (October 2006 to
December 2006). Approximately 400 files were analyzed
during this pre-test. It allowed improvements to be
made to the research procedure. A codebook was estab-
lished to harmonize the use the ICPC-2 coding system
within the research team. All health records were then
coded following this procedure. One coder (DB)
reviewed all the files and followed strict coding rules
established by the research team at the initiation of the
study. Coding doubts were discussed and resolved dur-
ing regular meetings both with another coder in a differ-
ent detention setting (DMH) and the entire research
team. All data were recorded anonymously. Our focus
was on somatic health problems and substance abuse. A
more detailed description of specific psychiatric health
problems are presented in a separate article [14].
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Statistical analysis and ethical approval
Descriptive statistics were computed for demographic
characteristics. The frequencies of ICPC-2 coded health
problems were computed with 95% confidence intervals.
Unless specified, we used Chi square tests to explore
possible associations between commonly occurring
health problems and patient characteristics. Age and
sex-adjusted odds ratios for the association between ori-
gin and health problems were obtained with logistic
regression models. Statistical analyses were done with S-
Plus 7.0 Enterprise Developer and SPSS 15.0. The
research project was approved by the Ethics Committee
of Geneva University Hospitals.
Results
Sociodemographic characteristics
Of 2195 prisoners leaving the prison during 2007, 1510
(68.8%) had a primary care consultation during their
stay and 685 (31.2%) only had an initial health assess-
ment by the nurse. Hundred-fifteen different national-
ities were represented and 92.8% detainees with at
least one medical consultation were of foreign origin.
Main regions of origin were Western Europe (28.9%),
followed by North Africa and Middle East (27.5%) and
Sub-Saharan Africa (20.1%). More details are shown in
table 1. Length of stay was short as 27% stayed less
than one week and 78% less than three months in the
prison.
ICPC coded health problems
Figure 1 describes the ICPC coded health problems
identified in 2195 health records. Morbidity was high;
both somatic (57.6%) and mental (32.6%) health pro-
blems were highly prevalent. There were no gender
differences in relation to the percentage of somatic
health problems which were observed in female
(61.1%; 95%CI 51.9-70.3) and male (57.4%; 95%CI
55.3-59.5) of detainees (p = 0.45). Major somatic
health problems were: 1. skin (27.0%), 2. musculoskele-
tal (19.2%), 3. digestive (15.0%) and 4. respiratory
(14.0%) disorders. Somatic disorders were slightly more
frequent in those 29 years (median) or older (64% vs.
53%, p < 0.0001). Mean number of identified health
problems were 2.4 (SD 1.8). Those who stayed less
than 1 month had a mean of 2.0 (SD 1.3), those who
stayed 3 to 6 months a mean of 3.2 (SD 2.0) and those
who stayed more than 6 months a mean of 4.1 (SD
2.6) identified health problems.
Symptoms or complaints without precise diagnosis
Symptoms or complaints without precise diagnosis, such
as insomnia, back pain or feeling anxious, were present
in 926 detainees (42.2%). Their prevalence is presented
in figure 2 and table 2.
Substance abuse
Substance abuse was frequent and observed in 1562
detainees (71.2%): 61.5% smoked tobacco and 34.8%
reported excessive alcohol consumption. Forty percent
used at least one illicit drug (heroin, cocaine or canna-
bis) in the 30 days before admission. Lifetime consump-
tion of cocaine or heroin was 33.8%. All substances
were more frequently used by men compared to women
(details are presented in figure 3 and table 3).
Infectious diseases
Infectious diseases were found in 23.5%. As shown in
figure 4, upper airway infection was the most frequent
infection, followed by fungal infections. Hepatitis C
infection was found in 5.7% of detainees and among
15.4% (95%CI 12.8-18.0) of those who used either heroin
or cocaine on admission. A fifth of Georgians, who also
showed high prevalence rates of illicit drug (see below),
were infected by HCV (20.8% CI95% 9.3-32.3). Only
0.8% (95%CI 0.4-1.3) of non-users of illicit drugs had
hepatitis C infection. Chronic Hepatitis B was identified
in 1% and HIV infection in 1% of the inmates.
Health problems grouped as “general internal medicine”
Thirty percent had health problems grouped in this
category (figure 5, table 2). Skin problems, such as xero-
sis with pruritus, acne or eczema were predominant in
this group. Asthma was the second most frequent health
problem, observed in 3.2% of men and 2.8% of women.
Diabetes was identified in 1.3% (CI95% 08-18) of male
and in no female detainee.
Psychiatric disorders (excluding substance abuse)
Excluding substance abuse, psychiatric problems were
found in 15.9% of men and 25% of women (figure 6).
Depression was observed more than twice as frequently
in women (16.7%) than in men (6.9%). Other frequently
observed disorders were personality (5.5%) and adjust-
ment disorders (4.5%).
Exposure to violence and injury
Injuries occurred in 18.3% of detainees and were more
than twice as frequent in men (18.8%) compared to
women (8.3%) (figure 7). Nearly one in ten detainees
alleged being a victim of violence during arrest; 90% of
these blaming the police. No significant gender differ-
ences were found but alleged exposure to violence by
the authorities was more frequently declared by younger
inmates (≤28 years) compared to older detainees (>28
years) (9.4% vs 6.1%, p = 0.0037).
Self harm (drug overdose, self-mutilation and swallow-
ing of foreign bodies) was observed in 1.9% of women
and 4.7% of men. No death occurred in the institution
during 2007.
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Origin-related health problems
Compared to Western Europeans who served as the
reference group, sub-Saharan Africans had a higher bur-
den of infectious diseases (OR 1.62, CI95% 1.21-2.17),
and detainees from North-Africa/Middle-East more psy-
chiatric problems (OR 1.47, CI95% (1.09-1.98). Other
statistical significant differences were observed only for
substance abuse related problems: Asians had a higher
prevalence of heroin use (OR 2.06, CI95%1.14-3.73). In
particular Georgians had high prevalence rates of illicit
drug use (56.2%, CI95% 42.2-70.3). A quarter of them
used heroin (27.1%; CI95% 14.5-39.7) and 31.2% cocaine
(CI95% 18.1-44.4). Detainees from North-Africa/Middle-
East were more likely to use benzodiazepines (OR 1.81;
CI95% 1.38-2.37), cocaine (OR 1.5, CI95% 1.13-2.01)
and alcohol (OR 1.48; CI95% 1.16-1.87). Lower rates
Table 1 Socio-demographic characteristics of 2195 detainees in a remand prison in Geneva, Switzerland, 2007
Variable Detainees with at least one
medical consultation N = 1510
Detainees without medical
consultation N = 685
All detainees N = 2195
Age (years (SD, range)) 30.1 (9.8, 18-82) 28.0 (8.8, 18-71)* 29.5 (9.5, 18-82)*
Sex male (n) 95% (1434) 95% (653) 95% (2087)
Length of stay in prison (days (SD, range)) 98 (179, 1-2635)** 37 (89, 1-1010)*** 80 (160, 1-2635)****
Origin (continent and 5 most frequent countries):
Western Europe§§ 27.4% (413) 32.7% (208) 28.9% (621)
France 8.9% (135) 9.4% (60) 9.1% (195)
Switzerland 7.7% (116) 8.6% (61) 8.2% (177)
Italy 2.3% (35) 2.4% (15) 2.3% (50)
Portugal 2.1% (31) 2.7% (17) 2.2% (48)
Spain 2.1% (31) 1.1% (7) 1.8% (38)
Eastern Europe 14.6% (221) 22.0% (140) 16.8% (361)
Albania 5.5% (83) 13.8% (88) 8.0% (171)
Romania 2.0% (30) 4.6% (29) 2.7% (59)
Russia 2.7% (40) 0.6% (4) 2.1% (44)
Kosovo 1.7% (25) 0.9% (6) 1.4% (31)
ex-Yugoslavia§ 1.6% (22) 1.4% (9) 1.4% (31)
North Africa and Middle East 30.6% (461) 20.3% (129) 27.5% (590)
Algeria 15.8% (239) 8.6% (55) 13.7% (294)
Palestine 5.8% (88) 3.1% (20) 5.0% (108)
Iraq 3.6% (55) 2.2% (14) 3.2% (69)
Morocco 3.6% (54) 1.7% (11) 3.0% (65)
Tunisia 1.7% (26) 2.5% (16) 2.0% (42)
Sub-Saharan Africa 20.9% (315) 18.2% (116) 20.1% (432)
Guinea 5.2% (78) 5.3% (34) 5.2% (112)
Sierra Leone 1.9% (29) 1.6% (10) 1.8% (39)
Ivory Coast 1.5% (23) 1.6% (10) 1.5% (33)
Congo 1.1% (16) 1.4% (9) 1.2% (25)
Mali 1.0% (15) 1.3% (8) 1.1% (23)
Asia 3.8% (57) 2.2% (14) 3.3% (71)
Georgia 2.7% (41) 1.1% (7) 2.2% (48)
Vietnam 0.2% (3) 0.5% (1) 0.2% (4)
Philippines 0.2% (3) - 0.1% (3)
Azerbaijan 0.1% (2) - 0.1% (2)
Uzbekistan 0.1% (2) - 0.1% (2)
America 2.8% (42) 4.4% (28) 3.3% (70)
Chile 0.7% (11) 0.6% (4) 0.7% (15)
Brazil 0.7% (10) 0.8% (5) 0.7% (15)
Peru 0.3% (4) 0.6% (4) 0.4% (8)
Colombia 0.1% (2) 0.9% (6) 0.4% (8)
Jamaica 0.3% (4) 0.2% (1) 0.2% (5)
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Figure 1 ICPC-2 coded health problems in 2195 of detainees in a remand prison in Geneva, Switzerland, 2007.
Figure 2 Symptoms coded without precise diagnosis (42.2%, 95%CI 40.1-44.3)
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Table 2 Frequencies of ICPC-2 coded health problems of 2195 medical files of detainees in a remand prison in
Geneva, Switzerland, 2007
Category (common examples) Males Females All detainees Prevalence data general population
N = 2087 N = 108 N = 2195
N % (95% CI) N 42.6 (33.3-51.9) N % (95% CI) %
A. Symptoms without precise diagnosis 880 42.2 (40.0-44.3) 46 14.8 (8.1-21.5) 926 42.2 (40.1-44.3)
Insomnia, sleep disturbance 310 14.9 (13.3-16.4) 16 19.4 (12.0-26.9) 326 14.9 (13.4-16.3) 4.1-6.9 [26]*
Anxiety, nervousness, irritability, anger 226 10.8 (9.5-12.2) 21 6.5 (1.8-11.1) 247 11.3 (9.9-12.6)
Back pain 154 7.4 (6.3-8.5) 7 6.5 (1.8-11.1) 161 7.3 (6.2-8.4) 5.2-8.8 [26]*
Epigastralgia, dyspepsia, pyrosis 96 4.6 (3.7-5.5) 3 2.8 (0.0-5.9) 99 4.5 (3.6-5.4) 3.7-4.4 [26]*
Pain (not specified) 89 4.3 (3.4-5.1) 2 1.9 (0.0-4.4) 91 4.1 (3.3-5.0)
B. Infectious diseases 485 23.2 (21.4-25.1) 31 28.7 (20.2-37.2) 516 23.5 (21.7-25.3)
Upper airways infection 155 7.4 (6.3-8.6) 13 12.0 (5.9-18.2) 168 7.7 (6.5-8.8)
Mycosis (genital excepted) 138 6.6 (5.6-7.8) 2 1.8 (0.0-4.3) 140 6.4 (4.0-5.8)
Folliculitis, Furunculosis 59 2.8 (2.1-3.5) 1 0.9 (0.0-2.7) 60 2.7 (2.1-3.4)
Other prison relevant infections:
Pediculosis, scabies 19 0.9 (0.5-1.3) 0 19 0.9 (0.5-1.3)
Hepatitis B (chronic active) 22 1.1 (0.6-1.5) 0 7.4 (2.5-12.3) 22 1.0 (0.6-1.4) 0.2 [36]
Hepatitis C 118 5.7 (4.7-6.6) 8 7.4 (2.5-12.3) 126 5.7 (4.8-6.7) 0.7-1.0 [20]
HIV, AIDS 19 0.9 (0.5-1.3) 5 2.8 (0-5.9) 22 1.0 (0.6-1.4) 0.3 [36]
Tuberculosis (active) 5 0.2 (0.0-0.4) 3 5 0.2 (0.0-0.6) 0.006 [19]
C. General internal medicine 319 29.7 (27.7-31.6) 37 34.3 (25.3-43.2) 656 29.9 (28.0-31.8)
Xerosis with pruritus 143 6.9 (5.8-7.9) 2 1.9 (0.0-4.4) 145 6.6 (5.6-7.6)
Asthma 67 3.2 (2.5-4.1) 3 2.8 (0.0-5.9) 70 3.2 (2.5-3.9) 2.5 [25]
Acne 51 2.4 (1.8-3.1) 4 3.7 (0.1-7.3) 55 2.5 (1.9-3.2)
Eye disease (without conjunctivitis) 54 2.6 (1.9-3.3) 1 0.9 (0.0-2.7) 55 2.5 (1.9-3.2)
Hypertension (arterial) 47 2.3 (1.6-2.9) 6 5.6 (1.2-9.9) 53 2.4 (1.8-3.1) 2.5-7.6 [24]*
Allergy 45 2.2 (1.5-2.8) 5 4.6 (0.7-8.6) 50 2.3 (1.7-2.9)
Eczema 47 2.3 (1.6-2.9) 2 1.9 (0.0-4.4) 49 2.2 (1.6-2.9)
Dyslipidemia, hypercholesterolemia 42 2.0 (1.4-2.6) 3 2.8 (0.0-5.9) 45 2.1 (1.5-2.6) 1.1-6.3 [24]*
Hemorrhoids 39 1.9 (1.3-2.4) 1 0.9 (0.0-2.7) 40 1.8 (1.3-2.4)
Migraine, tension headache 32 1.5 (1.0-2.1) 5 4.6 (0.7-8.6) 37 1.7 (1.1-2.2) 7.7-9.3 [26]
D. Injuries 392 18.8 (17.1-20.5) 9 8.3 (3.1-13.5) 401 18.3 (16.7-19.9) 13.7-25.7 [24]*
Alleged victim of violence 166 8.0 (6.8-9.1) 7 6.5 (1.7-11.1) 173 7.9 (6.8-9.0)
Contusion (without skin lesion) 141 6.8 (5.7-7.8) 7 6.5 (1.8-11.1) 148 6.7 (5.7-7.8)
Contusion (with skin lesion) 124 5.9 (4.9-7.0) 3 2.8 (0.0-5.9) 127 5.8 (4.8-6.8)
Sprained ankle 41 2.0 (1.4-2.6) 1 0.9 (0.0-2.7) 42 1.9 (1.3-2.5)
Periarticular lesion 33 1.6 (1.0-2.1) 0 33 1.5 (1.0-2.0)
Self harm 98 4.7 (3.8-5.6) 2 1.9 (0.0-4.4) 100 4.6 (3.7-5.4)
During imprisonment 50 2.4 (1.7-3.1) 1 0.9 (0.0-2.7) 51 2.3 (1.7-3.0)
Previous 57 2.7 (2.0-3.4) 1 0.9 (0.0-2.7) 58 2.6 (2.0-3.3)
*adults < 49 years
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were found for Eastern Europeans for cannabis (OR
0.67; CI95% 0.49-0.92) and alcohol misuse (OR 0.69;
CI95% 0.51-0.92).
Discussion
This study is the first to detail the wide range of health
problems among detainees in a Swiss remand prison.
Illicit drug use (40.2%) and mental health problems
(32.6%) were frequent in this mainly migrant population,
but most of these detainees (57.6%) required care for
common primary care problems, such as skin (27.0%),
infectious diseases (23.5%), musculoskeletal (19.2%),
injury related (18.3%), digestive (15.0%) or respiratory
problems (14.0%). Until recently Switzerland lacked
national comparative data concerning health problems
in primary care. With the advent of electronic medical
records this is slowly changing. A recent publication
provides data about ICPC-2 coded electronic medical
records of 24 Swiss GPs concerning 29’398 doctor-
patient encounters. Main reasons for encounter were
musculoskeletal (21%), circulatory (19%), respiratory
(9%) and endocrine, metabolic and nutritional disorders
(8%) [15]. Prevalence data in our study were different
for most health problems (with the exception of muscu-
loskeletal disorders). This adds value to our findings in
highlighting the extent to which primary care services in
prison may differ from those provided to the general
population. Our findings are consistent with findings in
Britain [16] and Belgium [4], where detainees consulted
3 to 3.8 times more frequently compared to the age-and
sex-adjusted general population. Main ICPC-2 code
groups in the Belgium study were the same as in ours.
Nearly 70% of detainees in our study had consultations
with a primary care physician. The high need for pri-
mary care services in prison can be explained by the
accumulation of negative social determinants of health
which contributes to a high burden of disease [2,4,17]
but also by improved access to health care services in
prison as well as the prison culture. For example, self-
medication is usually forbidden in prison. Prisoners
therefore have few opportunities to resort to self-care
and are more likely to request medical help even for
simple complaints [16].
Publications concerning US jail inmates report the fol-
lowing most frequent medical problems: arthritis (13-
20%), hypertension (11-21%), asthma (10-24%), heart
problems (5.9-11%), hepatitis (2.6-10%) and diabetes
(2.7-6.5%) [5,18] Gender differences were observed with
higher burden of chronic medical disorders, psychiatric
disorders and drug dependence in women compared to
men [18]. Our study identified higher burden of psy-
chiatric disorders in women, an equal burden of somatic
Figure 3 Health problems coded as substance abuse (71.2%; 95%CI 69.3-73.1)
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health problems in both groups and a higher burden of
drug dependence in men. Cardiovascular risk factors
such as hypertension (3.5%) and diabetes (1.2%) appear
to be less frequent in the population involved in our
study. As blood pressure was checked among all prison-
ers during the initial nurse evaluation, measurement
bias is unlikely to explain the low proportion of hyper-
tension in our study. In addition our findings in relation
to hypertension and diabetes are well in line with popu-
lation data in Switzerland, suggesting that, with the
exception of tobacco cessation counseling, these detai-
nees may have little need for cardiovascular preventive
care.
Our study identified prevalence rates ≥10 times those
found in the general population for tuberculosis (0.2%
vs. 0.006% [19]), HCV infection (5.7% vs. 0.7-1% [20]
and heroin use (12.3% vs. 0.7%[21]). Worldwide, TB-
notification rates are found to be 14.9 times higher in
prisoners compared to civilians, in Western Europe TB-
notification rates are 8.1-times higher [22]. The high
rates of infectious diseases and particularly of tuberculo-
sis are related to risk factors which aggregate in prison:
low socioeconomic status, intravenous drug use, home-
lessness, lack of access community based health care as
well as the origin of high TB-incidence countries
[22,23]. Our findings highlight the vulnerability of detai-
nees to TB and other infectious diseases and stress the
need for effective screening and containment measures
in prison [22]. The frequency of common health pro-
blems such as dyslipidemia, back pain, or epigastralgia
was well in line with that observed in the general Swiss
population [24-26]. Asthma was less frequently reported
than in prison settings in the US, UK or Australia
[18,23], but in accordance with general population data
of Switzerland [27].
Most psychiatric disorders were observed more fre-
quently than in the general population. However, the
proportion of detainees with psychiatric disorders was
low compared to available data from the literature
where prevalence rates of up to 65% for personality dis-
order (including 47% with antisocial personality) were
found [23,28]. Several reasons may explain these find-
ings. First, the health problems were identified by gen-
eral practitioners and not by specialists. The ICPC-2
Table 3 Frequencies of ICPC-2 coded health problems (Substance abuse, self harm and psychiatric disorders) of 2195
medical files of detainees in a remand prison in Geneva, Switzerland, 2007
Category (common examples) Males Females All detainees Prevalence data: General population
N = 2087 N = 108 N = 2195
N % (95% CI)
E. Substance abuse
Substance abuse (licit) 1502 72.0 (70.0-73.9) 60 55.6 (46.2-64.9) 1562 71.2 (69.3-73.1)
Tobacco (active) 1296 62.1 (60.0-64.2) 55 50.9 (41.5-60.4) 1351 61.5 (59.5-63.6) 29.3-37.2 [24]*
Alcohol misuse 750 35.9 (33.9-38.0) 13 12.0 (5.9-18.2) 763 34.8 (32.8-36.8) 3.9-4.8 [24]*
Benzodiazepine
(not medically prescribed)
465 22.3 (20.5-24.1) 13 12.0 (5.9-18.2) 478 21.8 (20.1-23.5)
Illicit drug use (active): 852 40.8 (38.7-42.9) 31 28.7 (20.2-37.2) 883 40.2 (38.2-42.3)
Cannabis 605 29.0 (27.0-30.9) 19 17.6 (10.4-24.8) 624 28.4 (26.5-30.3) 9.3 [24]
Cocaine 418 20.0 (18.3-21.7) 10 9.3 (3.8-14.7) 428 19.5 (17.8-21.2) 2.8 [21]**
Heroine 255 12.2 (10.8-13.6) 14 13.0 (6.6-19.3) 269 12.3 (10.9-13.6) 0.7 [21]**
Illicit drug use (lifetime): 720 34.5 (32.5-36.5) 21 19.4 (12.0-26.9) 741 33.8 (31.8-35.7)
Cocaine 673 32.2 (30.2-34.3) 17 15.7 (8.9-22.6) 690 31.4 (29.5-33.4) 2.8 [21]*
Heroine 369 17.7 (16.0-19.3) 17 15.7 (8.9-22.6) 386 17.6 (16.0-19.2) 0.7 [21]**
F. Psychiatry 332 15.9 (14.3-17.5) 27 25.0 (16.8-17.9) 359 16.4 (14.8-17.9)
Depression 145 6.9 (5.9-8.0) 18 16.7 (9.6-23.7) 163 7.4 (6.3-8.5) 2-9% major depression [29]
Personality disorder 111 5.3 (4.4-6.3) 9 8.3 (3.1-13.5) 120 5.5 (4.5-6.4) 1-3% antisocial personality disorder [29]
Adjustment disorder 90 4.3 (3.4-5.2) 8 7.4 (2.5-12.3) 98 4.5 (3.6-5.3) 5-20% in individuals seeking outpatient mental
health treatment [29]
Post Traumatic Stress Disorder 22 1.1 (0.6-1.5) 0 22 1.0 (0.6-1.4) 1-14% [29]
Psychosis
(schizophrenia, delirium)
17 0.8 (0.4-1.2) 4 3.7 (0.0-7.3) 21 1.0 (0.5-1.4) 0.2-2% schizophrenia [29]
Bipolar disorder 2 0.1 (0.0-0.2) 0 2 0.1 (0.0-0.2) 0.4-1.6 [29]
*adults < 49 years, ** active and previous
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Figure 4 Health problems coded as infectious diseases (23.5%; 95%CI 21.7-25.3)
Figure 5 Health problems coded as general internal medicine (29.9%; 95%CI 28.0-31.8)
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Figure 6 Health problems coded as psychiatry (16.4%; 95%CI 14.8-17.9)
Figure 7 Health problems coded as injuries (18.3%; 95%CI 16.7-19.9)
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tool favors the identification of symptoms and com-
plaints where diagnoses are not available and is particu-
larly adapted for ambulatory settings in primary care.
Second, we did not systematically use a diagnostic
screening interview which explains why certain diag-
noses were less prevalent in our study than usually
described in the literature. This appears to be particu-
larly true for long lasting problems such as personality
disorders compared with acutely symptomatic mental
disorders. Third, remand detainees differ from the local
Swiss population regarding several socio-demographic
characteristics, all of which are relevant for the preva-
lence, course and outcome of most mental disorders.
More specifically, compared with the general Swiss
population, detainees included in our study were
younger, more often foreign born and with lower socio-
economic status. However, in order to allow for a broad
comparison, ranges of prevalence mentioned in the
DSM-IV [29] for specific disorders are presented in
Table 3.
Our findings in relation to the high rates of heroin,
cocaine and benzodiazepine use were well in range with
those from previous studies, both in the US and in Eur-
ope [30-33]. That 40.2% detainees used at least one illi-
cit drug at entry highlights the need for general
practitioners (GP) working in detention to be well
trained in addiction medicine. Offering adequate care to
detainees who suffer from drug addiction is an impor-
tant priority. It is particularly important to implement
harm reduction strategies, such as opioid substitution
treatment which has been shown to be a powerful tool
to: 1. decrease the level of injecting, 2. prevent the trans-
mission of blood-borne viruses, 3. prevent drug-related
prison violence and crime following release as well as
recidivism [30,34]. Furthermore, excessive use of alcohol
(34.8%) and tobacco (61.5%) requires particular atten-
tion. Smoking rates were more than twice as high as in
the general population in Switzerland where 32% of
men and 23.8% of women smoked in 2007 [35]. Smok-
ing is highly problematic in confined institutions as
exposure to passive smoking is almost inevitable for
everyone: inmates, prison officers and health
professionals.
A challenge for the GP working in prison is continuity
of care. Disease management requires good coordination
with different health services before and after imprison-
ment. This is particularly important for medical man-
agement of infectious diseases such as hepatitis which is
more prevalent in prison compared to the general popu-
lation [36]. Fifty-six percent of iv drug users in Switzer-
land are infected with hepatitis C virus (HCV) [37]. Our
study identified hepatitis C in 15.4% of those who
reported using either heroin or cocaine on admission
compared to 0.8% who denied use of illicit drugs. Vescio
showed in a meta-analysis that HCV sero-prevalence in
prison is closely related to the proportion of iv drug
users in prison who are found to have a 24 times higher
risk of HCV infection [38]. We identified highest sex-
and age-adjusted opiate-consumption rates in Asians.
These findings are concordant with international preva-
lence studies which confirm high rates of opiate and
intravenous drug use in Asia. This region represents
almost one-quarter of people who inject drugs world-
wide [39]. In particular Georgia has one of the highest
intravenous drug use rates worldwide (4.2% of 15-64
year olds), compared to Switzerland where 0.65% of 15-
64 year olds inject drugs [40]. Georgians in our sample
had high prevalence rates of HCV infection which were
four times higher than the average (20.8% vs 5.7%).
High rates of hepatitis C in this sample, even in the
absence of a systematic screening policy, confirm the
need to develop such a policy in our setting, and coun-
try of origin could serve as a rough decision-making cri-
terion for ordering additional health screening.
Imprisonment has to be considered as an opportunity to
provide medical care and preventive measures to this
hard-to-reach population. Furthermore, hepatitis C
treatment is proven cost-effective in prison settings [41]
but can only be effective if the prison health services
and particularly the GP is able to achieve continuity of
care.
Following systematic screening upon admission,
alleged violence from the authorities was reported by 8%
of detainees. Our health service has set-up a system for
reporting these alleged violent events to a state ombuds-
man in order to favor a reduction in unethical behavior
in law enforcement state services.
In the absence of systematic screening policies in our
institution, the identification of problems such as STI,
AIDS, hepatitis and psychiatric illnesses was based on
clinical evaluation and/or patient requests for tests. This
may have led to underestimations of the frequency of
these health problems. Yet, our primary aim was not to
provide precise prevalence data but to offer data on fre-
quently encountered health problems in order to inform
prison healthcare services development. Even if our
findings provide conservative estimates of prevalence
rates, they underline the high morbidity in this popula-
tion in particular in relation to addiction and infectious
diseases but also in relation to more common health
problems seen in general practice. That all detainees
underwent a health evaluation and were systematically
referred to the physician when a medical problem was
identified adds strength to the notion that, despite its
limitations, our study provides a comprehensive picture
of the health status of this population.
Another limitation was that data were extracted retro-
spectively by only one coder, a primary care physician
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who had not necessarily been involved in the care of
each of the patients. Errors in coding, however, were
minimized by setting strict rules for coding at the initia-
tion of the study. Doubts were discussed and resolved in
regular meetings with the research team. Finally, we stu-
died a single facility in one country. Thus our findings
may not necessarily be generaliseable to other detention
centers in other countries. Yet we hypothesize that the
health profile described here would be comparable in
other detention centers where the sociodemographic
profile corresponds to that described here. The study
population was similar to that of other pre-trial prisons
in Switzerland, which are also characterized by high pro-
portions of migrants (81.4%) and males (94%) [6]. Fac-
tors contributing to the high rates of incarceration in
migrants include high rates of illegal migration through-
out Europe, the lower socio-economic status of this
group and the fact that they are less likely to be granted
a bail sentence. The high proportion of foreigners in
Swiss jails underlines the need for culturally-sensitive
approaches and non-stigmatizing attitudes towards this
vulnerable population.
Strengths of the study include the large sample size
including inmates of both genders. Information was
gathered on all inmates present in the detention facility
over an entire year. The use of the ICPC-2 coding sys-
tem allowed us to capture the full range of health needs
for which these inmates could benefit from primary care
services upon admission and during their incarceration.
Conclusions
The wide range of health problems that were identified
in this prison population highlights the need for GP
working in prison to acquire skills in many domains,
including general internal medicine, addiction medicine,
psychiatry and language- and culturally-appropriate
communication with patients. Prison health services and
prison authorities should carefully assess the possibilities
for strengthening self-care options in prison in order to
reduce the burden of self-limited illnesses on primary
care services. For many inmates, contact with the prison
health service is their first ever opportunity to meet a
health professional. Addressing the health needs of these
prisoners through well coordinated psychiatric and pri-
mary care services offers an opportunity to reach-out to
this hard-to-reach vulnerable population in the interest
of their individual health and of public health.
Additional material
Additional file 1: Questionnaire ICPC-2, prison Champ-Dollon,
Geneva, Switzerland 2007.
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